Bum Chun Suh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bum Chun Suh has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Soei Ann
Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
4 shared publications Heui-Soo Moon
3 shared publications- Hyung Jun Park
Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
3 shared publications Pil-Wook Chung
3 shared publications- Yong Kyun Kim
Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
3 shared publications - Young-Chul Choi
Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 28 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (3) , 864
The Use of Nerve Conduction Study to Evaluate the Effects of Frozen Sock Treatment on Docetaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Prospective Clinical Trial
Background/Objectives: Docetaxel is a cytotoxic agent for the treatment of breast cancer, and its toxicities include peripheral neuropathy (PN). This study evaluated the ability of frozen sock (FS) treatment to prevent docetaxel-induced PN by performing nerve conduction study (NCS). Methods: From October 2017 to October 2018, 48 patients who had invasive carcinoma and were planned for docetaxel treatment every three weeks were evaluated. Patients wore a FS on the right foot, and the left foot was not protected by the FS during docetaxel infusion. Motor and sensory NCS as well as nail and skin toxicities were assessed. Results: The amplitude and velocity of the motor and sensory nerves significantly decreased after three months in both feet. Before and after three months of chemotherapy, the compound motor action potentials (CMAPs) for the right peroneal nerve were 7.64 ± 2.42 and 6.81 ± 2.21 mV, respectively (p < 0.001), and 7.13 ± 2.41 and 5.90 ± 2.24 mV, respectively (p < 0.001), for the left peroneal nerve. Reductions in the CMAP amplitude of the peroneal nerve were significantly lower in the right foot compared to the left foot (−9.58 vs. −16.8, p = 0.043). Application of the FS did not significantly decrease the overall incidence of skin and nail toxicity compared with the left foot during the study period (all p > 0.05). Conclusions: Docetaxel induced motor and sensory PN, but the use of a FS resulted in a smaller reduction in peroneal nerve amplification three months after the end of chemotherapy.
- 28 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (3) , 864
Open AccessThe Use of Nerve Conduction Study to Evaluate the Effects of Frozen Sock Treatment on Docetaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Prospective Clinical Trial
Background/Objectives: Docetaxel is a cytotoxic agent for the treatment of breast cancer, and its toxicities include peripheral neuropathy (PN). This study evaluated the ability of frozen sock (FS) treatment to prevent docetaxel-induced PN by performing nerve conduction study (NCS). Methods: From October 2017 to October 2018, 48 patients who had invasive carcinoma and were planned for docetaxel treatment every three weeks were evaluated. Patients wore a FS on the right foot, and the left foot was not protected by the FS during docetaxel infusion. Motor and sensory NCS as well as nail and skin toxicities were assessed. Results: The amplitude and velocity of the motor and sensory nerves significantly decreased after three months in both feet. Before and after three months of chemotherapy, the compound motor action potentials (CMAPs) for the right peroneal nerve were 7.64 ± 2.42 and 6.81 ± 2.21 mV, respectively (p < 0.001), and 7.13 ± 2.41 and 5.90 ± 2.24 mV, respectively (p < 0.001), for the left peroneal nerve. Reductions in the CMAP amplitude of the peroneal nerve were significantly lower in the right foot compared to the left foot (−9.58 vs. −16.8, p = 0.043). Application of the FS did not significantly decrease the overall incidence of skin and nail toxicity compared with the left foot during the study period (all p > 0.05). Conclusions: Docetaxel induced motor and sensory PN, but the use of a FS resulted in a smaller reduction in peroneal nerve amplification three months after the end of chemotherapy.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Clinical Neurology
- Vol. 21 (1) , 31-39
Profiling of Anti-Signal-Recognition Particle Antibodies and Clinical Characteristics in South Korean Patients With Immune-Mediated Necrotizing Myopathy
Kim SH, et al. J Clin Neurol. 2025 Jan;21(1):31-39. https://doi.org/10.3988/jcn.2024.0333
- 1 January 2025
- Published by XMLink in Journal of Clinical Neurology
- Vol. 21 (1) , 31-39
Open AccessProfiling of Anti-Signal-Recognition Particle Antibodies and Clinical Characteristics in South Korean Patients With Immune-Mediated Necrotizing Myopathy
Kim SH, et al. J Clin Neurol. 2025 Jan;21(1):31-39. https://doi.org/10.3988/jcn.2024.0333
- Open Access
- 31 December 2023
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 25 (3) , 121-124
Immunoglobulin G4-Related Hypertrophic Pachymeningitis Presenting with Multiple Lower Cranial Nerve Palsies
Immunoglobulin G4-related disease (IgG4-RD) is a multi-organ condition that infrequently exhibits neurological involvement. Here, we describe a case of IgG4-related hypertrophic pachymeningitis with multiple lower cranial nerve palsies. A 65-year-old man presented with a 5-month history of hoarseness and dysphagia. A neurologic examination revealed multiple lower cranial nerve palsies. Brain magnetic resonance imaging indicated diffuse dural involvement along the left tentorium and temporal fossa. Serum IgG and IgG4 levels were found to be elevated. Ethmoid polyp biopsy revealed chronic inflammation with moderate lymphoplasmacytic and some eosinophilic infiltration. Up to 60 IgG4-positive cells were observed per high-power field, and the measured IgG4/IgG ratio was approximately 10% to 20%. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography indicated abnormally high FDG uptake in the left posterior fossa, tentorium, and left temporal fossa, with additional involvement of the lung, iliac artery, and renal artery. Based on these findings, we diagnosed the patient with IgG4-related hypertrophic pachymeningitis and successfully treated the condition with steroids and rituximab. IgG4-RD should be differentiated from distinct conditions presenting with multiple cranial nerve palsies accompanied by pachymeningitis.
- 31 December 2023
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 25 (3) , 121-124
Open AccessImmunoglobulin G4-Related Hypertrophic Pachymeningitis Presenting with Multiple Lower Cranial Nerve Palsies
Immunoglobulin G4-related disease (IgG4-RD) is a multi-organ condition that infrequently exhibits neurological involvement. Here, we describe a case of IgG4-related hypertrophic pachymeningitis with multiple lower cranial nerve palsies. A 65-year-old man presented with a 5-month history of hoarseness and dysphagia. A neurologic examination revealed multiple lower cranial nerve palsies. Brain magnetic resonance imaging indicated diffuse dural involvement along the left tentorium and temporal fossa. Serum IgG and IgG4 levels were found to be elevated. Ethmoid polyp biopsy revealed chronic inflammation with moderate lymphoplasmacytic and some eosinophilic infiltration. Up to 60 IgG4-positive cells were observed per high-power field, and the measured IgG4/IgG ratio was approximately 10% to 20%. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography indicated abnormally high FDG uptake in the left posterior fossa, tentorium, and left temporal fossa, with additional involvement of the lung, iliac artery, and renal artery. Based on these findings, we diagnosed the patient with IgG4-related hypertrophic pachymeningitis and successfully treated the condition with steroids and rituximab. IgG4-RD should be differentiated from distinct conditions presenting with multiple cranial nerve palsies accompanied by pachymeningitis.
- Open Access
- 15 December 2023
- Published by Korean Society of Geriatric Neurology in Journal of Geriatric Neurology
- Vol. 2 (2) , 85-87
Numb chin syndrome as the first manifestation of an advanced metastatic cancer
Dear Editor, Numb chin syndrome refers to reduced or absent sensation in an area over the chin and lower lip within the distribution of the mental or inferior alveolar nerves [1]. The term "numb chin syndrome" was first used in case reports of five patients who presented numbness on chin due to various malignancies in 1963 [2]. The chin numbness can be overlooked by patients and even clinicians because this is a pure sensory neuropathy limited to a relatively small area. However, numb chin syndrome can be associated with some fatal diseases. It may be the first and only manifestation of an advanced metastatic cancer [1,3-6]. In this case, the diagnosis will be severely delayed unless the clinician has suspicion and performs a thorough investigation. Here, we report a patient presenting with numb chin syndrome as the first manifestation of systemic malignancies. An 80 years-old male presented with left chin numbness, which he noticed 3 weeks ago. The symptom was initially numbness accompanied by throbbing pain in the left lower chin, but the pain improved afterwards and the hypoesthesia continued. He had no past medical history and there was no family history. Neurological examination revealed decreased sensation to touch and pain in mandibular division of trigeminal cranial nerve below the lower lip on left side with sparing of motor function of the trigeminal nerve. All other cranial nerves were intact, and other central nervous system examinations and the peripheral nervous examination were normal. Laboratory tests including serum tumor markers were not remarkable. We tested the blink reflex and confirmed the trigeminal nerve damage on the left side. A facial bone magnetic resonance imaging (MRI) showed soft tissue masses involving the ramus of both mandible, clivus, dorsum sella, and left maxilla, suggesting multiple bone metastases of cancer (Figure 1A, B). A whole-body 18 fluorine-fluorodeoxyglucose positron emission tomography study combined with computed tomography (18 F-FDG PET/CT) demonstrated multiple hypermetabolic bone lesions throughout most of the body including skull base, facial bones, spines, and four limbs, but there were no predominant lesions suggestive of primary cancer (Figure 1C, D). Additional tests including blood test, chest and abdomen CT were performed to find the primary cancer, but no significant findings were found. We consulted with the oncologist and the patient decided to continue oncology treatment through outpatient clinic and was discharged. Numb chin syndrome is a condition that can be easily overlooked because it is relatively mild
- 15 December 2023
- Published by Korean Society of Geriatric Neurology in Journal of Geriatric Neurology
- Vol. 2 (2) , 85-87
Open AccessNumb chin syndrome as the first manifestation of an advanced metastatic cancer
Dear Editor, Numb chin syndrome refers to reduced or absent sensation in an area over the chin and lower lip within the distribution of the mental or inferior alveolar nerves [1]. The term "numb chin syndrome" was first used in case reports of five patients who presented numbness on chin due to various malignancies in 1963 [2]. The chin numbness can be overlooked by patients and even clinicians because this is a pure sensory neuropathy limited to a relatively small area. However, numb chin syndrome can be associated with some fatal diseases. It may be the first and only manifestation of an advanced metastatic cancer [1,3-6]. In this case, the diagnosis will be severely delayed unless the clinician has suspicion and performs a thorough investigation. Here, we report a patient presenting with numb chin syndrome as the first manifestation of systemic malignancies. An 80 years-old male presented with left chin numbness, which he noticed 3 weeks ago. The symptom was initially numbness accompanied by throbbing pain in the left lower chin, but the pain improved afterwards and the hypoesthesia continued. He had no past medical history and there was no family history. Neurological examination revealed decreased sensation to touch and pain in mandibular division of trigeminal cranial nerve below the lower lip on left side with sparing of motor function of the trigeminal nerve. All other cranial nerves were intact, and other central nervous system examinations and the peripheral nervous examination were normal. Laboratory tests including serum tumor markers were not remarkable. We tested the blink reflex and confirmed the trigeminal nerve damage on the left side. A facial bone magnetic resonance imaging (MRI) showed soft tissue masses involving the ramus of both mandible, clivus, dorsum sella, and left maxilla, suggesting multiple bone metastases of cancer (Figure 1A, B). A whole-body 18 fluorine-fluorodeoxyglucose positron emission tomography study combined with computed tomography (18 F-FDG PET/CT) demonstrated multiple hypermetabolic bone lesions throughout most of the body including skull base, facial bones, spines, and four limbs, but there were no predominant lesions suggestive of primary cancer (Figure 1C, D). Additional tests including blood test, chest and abdomen CT were performed to find the primary cancer, but no significant findings were found. We consulted with the oncologist and the patient decided to continue oncology treatment through outpatient clinic and was discharged. Numb chin syndrome is a condition that can be easily overlooked because it is relatively mild
- Open Access
- 10 May 2023
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 53 (1) , 38-45
Topographic Consideration on the Occurrence of Ipsilesional Facial Paresis in Lateral Medullary Infarction
Introduction: The purpose of this study was to identify course of the corticobulbar tract and factors associated with the occurrence of facial paresis (FP) in lateral medullary infarction (LMI). Methods: Patients diagnosed with LMI who were admitted to tertiary hospital were retrospectively investigated and divided into two groups based on the presence of FP. FP was defined as grade 2 or more by the House-Brackmann scale. Differences between the two groups were analyzed with respect to anatomical location of the lesions, demographic data (age, sex), risk factors (diabetes, hypertension, smoking, prior stroke, atrial fibrillation, and other cardiac risk factors for stroke), large vessel involvement on magnetic resonance angiography, other symptoms and signs (sensory symptoms, gait ataxia, limb ataxia, dizziness, Horner syndrome, hoarseness, dysphagia, dysarthria, nystagmus, nausea/vomiting, headache, neck pain, diplopia, and hiccup). Results: Among 44 LMI patients, 15 patients (34%) had FP, and all of them had ipsilesional central-type FP. The FP group tended to involve upper (p < 0.0001) and relative ventral (p = 0.019) part of the lateral medulla. Horizontally large lesion was also related to the presence of FP (p = 0.044). Dysphagia (p = 0.001), dysarthria (p = 0.003), and hiccups (p = 0.034) were more likely to be accompanied by FP. Otherwise, there were no significant differences. Conclusion: The results of present study indicate that the corticobulbar fibers innervating the lower face decussate at the upper level of the medulla and ascend through the dorsolateral medulla, where the concentration of the fibers is densest near the nucleus ambiguus.
- 10 May 2023
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 53 (1) , 38-45
Open AccessTopographic Consideration on the Occurrence of Ipsilesional Facial Paresis in Lateral Medullary Infarction
Introduction: The purpose of this study was to identify course of the corticobulbar tract and factors associated with the occurrence of facial paresis (FP) in lateral medullary infarction (LMI). Methods: Patients diagnosed with LMI who were admitted to tertiary hospital were retrospectively investigated and divided into two groups based on the presence of FP. FP was defined as grade 2 or more by the House-Brackmann scale. Differences between the two groups were analyzed with respect to anatomical location of the lesions, demographic data (age, sex), risk factors (diabetes, hypertension, smoking, prior stroke, atrial fibrillation, and other cardiac risk factors for stroke), large vessel involvement on magnetic resonance angiography, other symptoms and signs (sensory symptoms, gait ataxia, limb ataxia, dizziness, Horner syndrome, hoarseness, dysphagia, dysarthria, nystagmus, nausea/vomiting, headache, neck pain, diplopia, and hiccup). Results: Among 44 LMI patients, 15 patients (34%) had FP, and all of them had ipsilesional central-type FP. The FP group tended to involve upper (p < 0.0001) and relative ventral (p = 0.019) part of the lateral medulla. Horizontally large lesion was also related to the presence of FP (p = 0.044). Dysphagia (p = 0.001), dysarthria (p = 0.003), and hiccups (p = 0.034) were more likely to be accompanied by FP. Otherwise, there were no significant differences. Conclusion: The results of present study indicate that the corticobulbar fibers innervating the lower face decussate at the upper level of the medulla and ascend through the dorsolateral medulla, where the concentration of the fibers is densest near the nucleus ambiguus.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Clinical Neurology
- Vol. 19 (5) , 460-468
Clinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy
Oh EK, et al. J Clin Neurol. 2023 Mar;19:e27. https://doi.org/10.3988/jcn.2022.0374
- 1 January 2023
- Published by XMLink in Journal of Clinical Neurology
- Vol. 19 (5) , 460-468
Open AccessClinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy
Oh EK, et al. J Clin Neurol. 2023 Mar;19:e27. https://doi.org/10.3988/jcn.2022.0374
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Clinical Neurology
- Vol. 19 (3) , 296-303
Characteristics of Diverse Verbal Pain Descriptors in South Korean Patients With Peripheral Neuropathic Pain: ‘Jeorim’ (Tingling) and ‘Sirim’ (Cold) as Key Neuropathic Pain Descriptors
Choi K, et al. J Clin Neurol. 2023 Feb;19:e13. https://doi.org/10.3988/jcn.2022.0105
- 1 January 2023
- Published by XMLink in Journal of Clinical Neurology
- Vol. 19 (3) , 296-303
Open AccessCharacteristics of Diverse Verbal Pain Descriptors in South Korean Patients With Peripheral Neuropathic Pain: ‘Jeorim’ (Tingling) and ‘Sirim’ (Cold) as Key Neuropathic Pain Descriptors
Choi K, et al. J Clin Neurol. 2023 Feb;19:e13. https://doi.org/10.3988/jcn.2022.0105
- Open Access
- 30 April 2022
- Published by The Korean Society of Clinical Neurophysiology in Annals of Clinical Neurophysiology
- Vol. 24 (1) , 1-6
Quantitative sudomotor axon reflex test (QSART) as a diagnostic tool of small fiber neuropathy
Small fiber neuropathy is a painful neuropathy that cannot be assessed using nerve conduction studies. A skin biopsy and quantitative sensory testing (QST) are the gold standards for small fiber neuropathy diagnosis. However, a skin biopsy is invasive and commercially unavailable in Korea. QST is a method involving a thermal threshold, but its results can be affected by cognition as well as lesions of the central nervous system. Quantitative sudomotor axon reflex test (QSART) is a quantitative method of assessing sweat glands innervated by small fibers. In this review, we assessed the utility of QSART in evaluating small fiber neuropathy.
- 30 April 2022
- Published by The Korean Society of Clinical Neurophysiology in Annals of Clinical Neurophysiology
- Vol. 24 (1) , 1-6
Open AccessQuantitative sudomotor axon reflex test (QSART) as a diagnostic tool of small fiber neuropathy
Small fiber neuropathy is a painful neuropathy that cannot be assessed using nerve conduction studies. A skin biopsy and quantitative sensory testing (QST) are the gold standards for small fiber neuropathy diagnosis. However, a skin biopsy is invasive and commercially unavailable in Korea. QST is a method involving a thermal threshold, but its results can be affected by cognition as well as lesions of the central nervous system. Quantitative sudomotor axon reflex test (QSART) is a quantitative method of assessing sweat glands innervated by small fibers. In this review, we assessed the utility of QSART in evaluating small fiber neuropathy.
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (3) , e8
Subgrouping of Peripheral Neuropathic Pain Patients According to Sensory Symptom Profile Using the Korean Version of the PainDETECT Questionnaire
Choi K, et al. J Korean Med Sci. 2021 Dec;37(3):e8. https://doi.org/10.3346/jkms.2022.37.e8
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (3) , e8
Open AccessSubgrouping of Peripheral Neuropathic Pain Patients According to Sensory Symptom Profile Using the Korean Version of the PainDETECT Questionnaire
Choi K, et al. J Korean Med Sci. 2021 Dec;37(3):e8. https://doi.org/10.3346/jkms.2022.37.e8
- 1 November 2021
- Published by Korean Neurological Association in Journal of the Korean Neurological Association
- Vol. 39 (4) , 359-361
Subacute Combined Degeneration Associated with Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism
- 1 November 2021
- Published by Korean Neurological Association in Journal of the Korean Neurological Association
- Vol. 39 (4) , 359-361
Subacute Combined Degeneration Associated with Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism